Jing Li

Jing Li


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
NFNa Fan
Na Fan
ZHZhonggui He
Zhonggui He
PMPingping Ma
Pingping Ma
XWXin Wang
Xin Wang
CLChang Li
Chang Li
JLJing Li
Jing Li

7 January 2020 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
XSXianbao Shi
Xianbao Shi
NFNa Fan
Na Fan
GZGang Zhang
Gang Zhang
JSJin Sun
Jin Sun
ZHZhonggui He
Zhonggui He
JLJing Li
Jing Li
The aim of this study was to investigate the effect of amorphous solid dispersions (ASDs) on the dissolution rate and oral bioavailability of Quercetin (Que). First, we prepared the Que ASDs with various excipients using hot-melt extrusion to find the best option. X-ray diffraction (XRD), infrared spectroscopy (IR), and Raman spectroscopy were used to examine the solid formation of Que. Wetting process was studied by contact angle and solution process. The abilities of HPMC to inhibit crystallization and improve membrane permeability were demonstrated by fluorescence spectroscopy, dynamic light scattering analysis, in vitro permeability experiment and pharmacokinetics studies. Que existed as amorphous in solid dispersions, and poloxamer 188 (F68) was the best excipient for improving Que dissolution. Study on ASDs wettability proved Que ASDs improved wetting property in the presence of the F68. Furthermore, Que/F68/HPMC 1/4/3 and 1/5/2 ASDs belonged to drug-controlled diffusion; Que/F68/HPMC 1/6/1 ASDs belonged to drug/carrier-controlled diffusion; Que/F68 1/7 ASDs belonged to carrier-controlled diffusion. Addition of HPMC significantly inhibited the crystallization, improved membrane permeability and promoted drug absorption of compound Que. Que ASDs prepared enhanced solubility and intestinal absorption. Thus, Que ASDs provide a potent and efficacious formulation for Que oral administration.

1 November 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
NFNa Fan
Na Fan
PMPingping Ma
Pingping Ma
XWXin Wang
Xin Wang
CLChang Li
Chang Li
XZXiaorui Zhang
Xiaorui Zhang
ZHZhonggui He
Zhonggui He

1 September 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
CLChang Li
Chang Li
NFNa Fan
Na Fan
JLJing Li
Jing Li
ZHZhonggui He
Zhonggui He
JSJin Sun
Jin Sun

1 September 2018 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JZJiahua Zhou
Jiahua Zhou
FZFengchang Zhu
Fengchang Zhu
JLJing Li
Jing Li
Yongjun WangYongjun Wang
Yongjun Wang

1 January 2020 in Asian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
CLChang Li
Chang Li
XWXin Wang
Xin Wang
HSHang Song
Hang Song
SDShuai Deng
Shuai Deng
WLWei Li
Wei Li
JSJin Sun
Jin Sun
Albumin has been widely applied for rational design of drug delivery complexes as natural carriers in cancer therapy due to its distinct advantages of biocompatibility, abundance, low toxicity and versatile property. Hence, various types of multifunctional albumin-based nanoplatforms (MAlb-NPs) that adopt multiple imaging and therapeutic techniques have been developed for cancer diagnosis and treatment. Stimuli-responsive release, including reduction-sensitive, pH-responsive, concentration-dependent and photodynamic-triggered, is important to achieve low-toxicity cancer therapy. Several types of imaging techniques can synergistically improve the effectiveness of cancer therapy. Therefore, combinational theranostic is considered to be a prospective strategy to improve treatment efficiency, minimize side effects and reduce drug resistance, which has received tremendous attentions in recent years. In this review, we highlight several stimuli-responsive albumin nanoplatforms for combinational theranostic.